Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000897069-08-000590
Filing Date
2008-03-14
Accepted
2008-03-14 14:24:27
Documents
3
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT cmw3430.htm 6-K 664415
2 GRAPHIC kpmg.gif GRAPHIC 1723
3 COMMON STOCK PRIVATE PURCHASE AGMT. cmw3430a.htm EX-99 114723
  Complete submission text file 0000897069-08-000590.txt   783099
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 514-332-32
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 08688956
SIC: 2835 In Vitro & In Vivo Diagnostic Substances